LONDON, Sept 14 (Reuters) - Icelandic drugmaker Actavis (ACT.IC: Quote, Profile, Research), currently fighting for control of Croatia’s Pliva (PLV.ZA: Quote, Profile, Research), has received a warning letter from the U.S. Food and Drug Administration about one of its factories, it said on Thursday.
